• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振成像用于心房颤动的管理。

Cardiac MRI to Manage Atrial Fibrillation.

作者信息

Zhao Yan, Dagher Lilas, Huang Chao, Miller Peter, Marrouche Nassir F

机构信息

Tulane Research Innovation for Arrhythmia Discoveries (TRIAD), Heart and Vascular Institute, Tulane University School of Medicine, LA, US.

出版信息

Arrhythm Electrophysiol Rev. 2020 Dec;9(4):189-194. doi: 10.15420/aer.2020.21.

DOI:10.15420/aer.2020.21
PMID:33437486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7788396/
Abstract

AF is the most common arrhythmia in clinical practice. In addition to the severe effect on quality of life, patients with AF are at higher risk of stroke and mortality. Recent studies have suggested that atrial and ventricular substrate play a major role in the development and maintenance of AF. Cardiac MRI has emerged as a viable tool for interrogating the underlying substrate in AF patients. Its advantage includes localisation and quantification of structural remodelling. Cardiac MRI of the atrial substrate is not only a tool for management and treatment of arrhythmia, but also to individualise the prevention of stroke and major cardiovascular events. This article provides an overview of atrial imaging using cardiac MRI and its clinical implications in the AF population.

摘要

房颤是临床实践中最常见的心律失常。除了对生活质量有严重影响外,房颤患者发生中风和死亡的风险更高。最近的研究表明,心房和心室基质在房颤的发生和维持中起主要作用。心脏磁共振成像已成为一种可行的工具,用于探究房颤患者的潜在基质。其优势包括对结构重塑进行定位和定量。心房基质的心脏磁共振成像不仅是心律失常管理和治疗的工具,也是个体化预防中风和重大心血管事件的工具。本文概述了使用心脏磁共振成像进行心房成像及其在房颤人群中的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/7788396/f101f1a9847d/aer-09-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/7788396/c90c7c15b786/aer-09-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/7788396/f101f1a9847d/aer-09-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/7788396/c90c7c15b786/aer-09-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/7788396/f101f1a9847d/aer-09-189-g002.jpg

相似文献

1
Cardiac MRI to Manage Atrial Fibrillation.心脏磁共振成像用于心房颤动的管理。
Arrhythm Electrophysiol Rev. 2020 Dec;9(4):189-194. doi: 10.15420/aer.2020.21.
2
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.心房颤动管理的上游治疗:临床证据回顾及其对欧洲心脏病学会指南的影响。第一部分:一级预防。
Europace. 2011 Mar;13(3):308-28. doi: 10.1093/europace/eur002.
3
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.评估心房颤动背后的心房肌病:识别致心律失常和致血栓形成基质。
Circulation. 2015 Jul 28;132(4):278-91. doi: 10.1161/CIRCULATIONAHA.115.016795.
4
Pharmacological approaches in the treatment of atrial fibrillation.心房颤动治疗中的药理学方法。
Curr Med Chem. 2004 Jan;11(1):13-28. doi: 10.2174/0929867043456241.
5
Treatment of atrial fibrillation.心房颤动的治疗。
Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5.
6
Atrial fibrillation in horses part 1: Pathophysiology.马的心房颤动第 1 部分:病理生理学。
Vet J. 2020 Sep;263:105521. doi: 10.1016/j.tvjl.2020.105521. Epub 2020 Jul 23.
7
Atrial Myopathy Underlying Atrial Fibrillation.心房颤动的潜在心房肌病
Arrhythm Electrophysiol Rev. 2020 Aug;9(2):61-70. doi: 10.15420/aer.2020.13.
8
New Strategies for the Treatment of Atrial Fibrillation.心房颤动的治疗新策略
Pharmaceuticals (Basel). 2021 Sep 15;14(9):926. doi: 10.3390/ph14090926.
9
New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.心房颤动管理的新方法:对一个快速发展领域的批判性综述。
Drugs. 2002;62(16):2377-97. doi: 10.2165/00003495-200262160-00005.
10
Management of Atrial Fibrillation in Patients With Kidney Disease.肾病患者心房颤动的管理
J Atr Fibrillation. 2014 Apr 30;6(6):989. doi: 10.4022/jafib.989. eCollection 2014 Apr-May.

引用本文的文献

1
Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model.达格列净与沉默信息调节因子1的相互作用及在链脲佐菌素诱导的啮齿动物糖尿病模型中改善心房颤动的机制
Biomol Biomed. 2025 Jan 30;25(3):608-622. doi: 10.17305/bb.2024.11361.
2
Obesity: the perfect storm for heart failure.肥胖:心力衰竭的完美风暴。
ESC Heart Fail. 2024 Aug;11(4):1841-1860. doi: 10.1002/ehf2.14641. Epub 2024 Mar 15.
3
Directed Graph Mapping exceeds Phase Mapping for the detection of simulated 2D meandering rotors in fibrotic tissue with added noise.

本文引用的文献

1
Left atrial functional and structural changes associated with ablation of atrial fibrillation - Cardiac magnetic resonance study.与心房颤动消融相关的左心房功能和结构变化——心脏磁共振研究
Int J Cardiol. 2020 Apr 15;305:154-160. doi: 10.1016/j.ijcard.2019.12.010. Epub 2019 Dec 6.
2
Left atrial fibrosis progression detected by LGE-MRI after ablation of atrial fibrillation.左心房纤维化在房颤消融后的 LGE-MRI 检测中的进展。
Pacing Clin Electrophysiol. 2020 Apr;43(4):402-411. doi: 10.1111/pace.13866.
3
Late Gadolinium Enhancement Magnetic Resonance Imaging Guided Treatment of Post-Atrial Fibrillation Ablation Recurrent Arrhythmia.
定向图映射在检测纤维化组织中添加噪声的模拟 2D 蜿蜒转子方面优于相位映射。
Comput Biol Med. 2024 Mar;171:108138. doi: 10.1016/j.compbiomed.2024.108138. Epub 2024 Feb 16.
4
Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation.炎症生物标志物与心房颤动中胶原重塑蛋白的相互关系。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231165055. doi: 10.1177/10760296231165055.
5
Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.左心房心肌病变在心房颤动和心力衰竭中的临床意义、机制和治疗靶点。
Curr Heart Fail Rep. 2021 Jun;18(3):85-98. doi: 10.1007/s11897-021-00510-5. Epub 2021 Apr 17.
晚期钆增强磁共振成像引导治疗心房颤动消融后复发性心律失常。
Circ Arrhythm Electrophysiol. 2019 Aug;12(8):e007174. doi: 10.1161/CIRCEP.119.007174. Epub 2019 Aug 19.
4
Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study.左心房机械功能与 AF 无关的缺血性脑血管事件:来自 MESA 研究的见解。
JACC Cardiovasc Imaging. 2019 Dec;12(12):2417-2427. doi: 10.1016/j.jcmg.2019.02.021. Epub 2019 Apr 17.
5
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132. doi: 10.1016/j.jacc.2019.01.011. Epub 2019 Jan 28.
6
Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging.非心房颤动个体的心房纤维化与心脏磁共振钆延迟增强成像预测心房颤动
J Cardiovasc Electrophysiol. 2019 Apr;30(4):550-556. doi: 10.1111/jce.13846. Epub 2019 Jan 24.
7
Delayed Gadolinium Enhancement Magnetic Resonance Imaging Detected Anatomic Gap Length in Wide Circumferential Pulmonary Vein Ablation Lesions Is Associated With Recurrence of Atrial Fibrillation.延迟钆增强磁共振成像检测到的广泛环形肺静脉消融病变中的解剖间隙长度与心房颤动复发相关。
Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006659. doi: 10.1161/CIRCEP.118.006659.
8
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data.延迟钆增强磁共振成像与导管消融治疗心房颤动相关性心房纤维化:5 年随访数据。
J Am Heart Assoc. 2018 Dec 4;7(23):e006313. doi: 10.1161/JAHA.117.006313.
9
Clinical workflow and applicability of electrophysiological cardiovascular magnetic resonance-guided radiofrequency ablation of isthmus-dependent atrial flutter.电生理心血管磁共振引导的峡部依赖性房扑射频消融的临床工作流程和适用性。
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):147-156. doi: 10.1093/ehjci/jey143.
10
New Insights Into the Use of Cardiac Magnetic Resonance Imaging to Guide Decision Making in Atrial Fibrillation Management.心脏磁共振成像在房颤管理中指导决策的新见解。
Can J Cardiol. 2018 Nov;34(11):1461-1470. doi: 10.1016/j.cjca.2018.07.007. Epub 2018 Jul 12.